Canada markets closed

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.08-0.16 (-1.42%)
At close: 04:00PM EDT
10.70 -0.38 (-3.43%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 13.70M
Enterprise Value -12.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.29
Price/Book (mrq)0.51
Enterprise Value/Revenue -0.30
Enterprise Value/EBITDA 1.21

Trading Information

Stock Price History

Beta (5Y Monthly) 0.50
52-Week Change 3-82.87%
S&P500 52-Week Change 322.38%
52 Week High 380.80
52 Week Low 310.60
50-Day Moving Average 313.66
200-Day Moving Average 317.51

Share Statistics

Avg Vol (3 month) 313.9k
Avg Vol (10 day) 340.78k
Shares Outstanding 51.24M
Implied Shares Outstanding 61.27M
Float 8764.82k
% Held by Insiders 17.43%
% Held by Institutions 139.02%
Shares Short (Apr 15, 2024) 4301
Short Ratio (Apr 15, 2024) 40.02
Short % of Float (Apr 15, 2024) 40.02%
Short % of Shares Outstanding (Apr 15, 2024) 40.02%
Shares Short (prior month Mar 15, 2024) 4519

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:80
Last Split Date 3Apr 23, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -57.33%
Operating Margin (ttm)-422.02%

Management Effectiveness

Return on Assets (ttm)-14.76%
Return on Equity (ttm)-89.76%

Income Statement

Revenue (ttm)42.81M
Revenue Per Share (ttm)38.03
Quarterly Revenue Growth (yoy)-77.80%
Gross Profit (ttm)N/A
EBITDA -13.94M
Net Income Avi to Common (ttm)-24.54M
Diluted EPS (ttm)-21.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.37M
Total Cash Per Share (mrq)21.32
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.24
Book Value Per Share (mrq)21.64

Cash Flow Statement

Operating Cash Flow (ttm)-53.82M
Levered Free Cash Flow (ttm)-26.68M